AOA 2023: Diving into new data on MiSight contact lenses for myopia management
June 26th 2023At AOA Optometry's Meeting 2023, in Washington, DC, Justin Kwan, OD, FAAO, provides updates on the latest at CooperVision, including new data on MiSight myopia management contact lenses and information on their ortho-K software, Visavy.
AOA 2023: Pooled analysis of Gobi and Mojave studies for NOV03 treatment of MGD
June 23rd 2023Ahmad M. Fahmy, OD, FAAO, Dipl ABO, gives highlights of his AOA 2023 poster that was a pooled analysis of the Gobi and Mojave studies relevant to perfluorohexyloctane (NOV03) for dry eye disease associated with Meibomian gland dysfunction.
AOA 2023: Surgical interventions should be considered earlier in glaucoma treatment
June 22nd 2023Justin Schweitzer, OD, FAAO, and Nathan Lighthizer, OD, provide key takeaways from their 2023 AOA presentation, "Beyond drops: Surgical considerations in glaucoma," which they will give alongside Walter Whitley, OD, MBA, FAAO.
Bausch + Lomb celebrates US launch of Infuse Multifocal SiHy daily disposable contact lenses
June 5th 2023Infuse Multifocal silicone hydrogel (SiHy) daily disposable contact lenses leverage Bausch + Lomb’s proprietary lens tech to deliver all-day comfort and seamless transitions between near, intermediate, and distance vision for patients with presbyopia.
Alimera nabs US commercial rights for Yutiq
May 18th 2023Today, Alimera Sciences announced that they have acquired the US commercial rights of Yutiq (fluocinolone acetonide intravitreal insert) 0.18mg for the treatment of chronic non-infectious uveitis. Yutiq now joins Iluvien (fluocinolone acetonide intravitreal insert) 0.19 mg for DME in Alimera’s retina portfolio.